Paragon Wealth Strategies’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Paragon Wealth Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-213	Closed	-$1.94K	–	212
2022 Q4	$1.94K	Hold	213	–	–	﹤0.01%	197
2022 Q3	$2K	Buy	+213	New	+$1.88K	﹤0.01%	155
2021 Q3	–	Sell	-213	Closed	-$2K	–	256
2021 Q2	$2K	Buy	+213	New	+$2.25K	﹤0.01%	273

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Paragon Wealth Strategies's TEVA Position: Q1 2023 in Review

Paragon Wealth Strategies sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2023, closing a stake of 213 shares — an estimated $1.94K sold.

Paragon Wealth Strategies first reported a position in TEVA in Q2 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

Paragon Wealth Strategies reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2023 after selling out during the quarter.
Paragon Wealth Strategies sold 213 Teva Pharmaceutical Industries Limited shares in Q1 2023, an estimated $1.94K.
Paragon Wealth Strategies first reported a position in Teva Pharmaceutical Industries Limited in Q2 2021 and held it in 3 quarters.
Paragon Wealth Strategies's Teva Pharmaceutical Industries Limited position peaked at $2K in Q3 2022.
438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2023.

Based on Paragon Wealth Strategies's 13F filing for Q1 2023, filed 26 Apr 2023.